Guide — Renal · Med-Surg
UTI & Urosepsis Nursing Guide
UTI classification (uncomplicated/complicated, cystitis/pyelonephritis/CAUTI), clinical manifestations, urinalysis interpretation, urosepsis recognition, antibiotic selection overview, CAUTI prevention bundle, and patient education.
9 min read · Renal · Med-Surg
Educational use only. Antibiotic selection is guided by culture results, local resistance patterns, and provider clinical judgment. Always obtain culture before initiating antibiotics when possible. This material supports nursing education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional policy, or medical direction. Always follow facility protocols and current provider orders.
UTI Risk Factors
| Factor | Mechanism / Clinical Significance |
|---|---|
| Female anatomy | Short urethra (3–4 cm vs ~20 cm in males) → bacteria enter bladder more easily. Most common risk factor for recurrent UTI in women. |
| Sexual activity | "Honeymoon cystitis" — sexual intercourse introduces bacteria. Post-coital voiding reduces risk. |
| Urinary catheterization | Bypasses urethral defenses. Risk increases 3–7%/day. Most important HAI. |
| Obstruction | BPH, renal calculi, strictures, neurogenic bladder — urinary stasis promotes bacterial growth |
| Diabetes mellitus | Glucosuria (medium for bacteria), impaired immune function, autonomic neuropathy (incomplete bladder emptying) |
| Immunocompromise | HIV, transplant, chemotherapy, steroids — impaired ability to fight infection |
| Postmenopause | Loss of estrogen → loss of Lactobacillus (normal flora), changes in vaginal pH → increased colonization with gram-negative bacteria |
| Pregnancy | Progesterone-induced ureteral dilation (urinary stasis), mechanical compression. Always treat UTI in pregnancy — risk of pyelonephritis, preterm labor, low birth weight. |
UTI Types
Uncomplicated Cystitis (Lower UTI)
Bladder infection in otherwise healthy, non-pregnant adult without structural or functional urinary abnormalities
| Symptoms | Dysuria (hallmark), urinary frequency, urgency, suprapubic pain/tenderness, hematuria; NO fever, NO flank pain, NO systemic symptoms |
| Common organisms | E. coli (80%), Staphylococcus saprophyticus (young women), Klebsiella, Proteus |
| Urinalysis | Positive leukocyte esterase, positive nitrites, WBCs (> 5/HPF), bacteria; positive culture confirms the diagnosis |
| Treatment overview | Nitrofurantoin 100mg BID × 5 days OR TMP-SMX × 3 days OR fosfomycin single dose (local resistance patterns guide choice). Not fluoroquinolones first-line (resistance, side effects). |
| Nursing Action | Midstream clean-catch specimen collection education. Encourage fluid intake. Confirm culture results if treated empirically. Wipe front to back after toileting. No catheter for uncomplicated UTI. |
| NCLEX Pearl | Dysuria + frequency + NO fever = cystitis (lower UTI). Nitrofurantoin contraindicated with eGFR < 30. Culture BEFORE antibiotics whenever possible. |
Complicated UTI
UTI with factors that increase risk of treatment failure, resistant organisms, or severe outcomes
| Symptoms | Same as cystitis + may have systemic symptoms. Men: UTI always considered complicated (prostatitis risk). |
| Common organisms | Broader spectrum including Pseudomonas, Enterococcus, Klebsiella, Serratia, resistant organisms (ESBL-producing bacteria) |
| Urinalysis | Same as uncomplicated but culture particularly important — resistance patterns matter more |
| Treatment overview | Culture-guided antibiotic selection; longer courses (7–14 days); may require IV antibiotics initially. Remove catheter when possible. |
| Nursing Action | Obtain urine culture before antibiotics. Monitor closely — higher risk of progression to pyelonephritis or urosepsis. Identify and address precipitating factors (obstruction, catheter, instrumentation). |
| NCLEX Pearl | Any UTI in a man = complicated (assume prostatitis possible, requires longer treatment). UTI in pregnancy = always treated regardless of symptoms (risk of pyelonephritis + preterm labor). |
Pyelonephritis (Upper UTI)
Bacterial infection of the renal parenchyma and collecting system; ascending infection from bladder
| Symptoms | Fever and rigors (hallmark of upper tract involvement), CVA (costovertebral angle) tenderness, flank pain, nausea/vomiting, PLUS lower UTI symptoms. May be severely ill. |
| Common organisms | E. coli (most common), Klebsiella, Enterobacter, Proteus |
| Urinalysis | WBCs, bacteria, WBC casts (hallmark — confirms renal parenchymal involvement), nitrites, leukocyte esterase, positive culture |
| Treatment overview | Mild-moderate: oral fluoroquinolone × 7 days or TMP-SMX × 14 days. Severe/hospitalized: IV ceftriaxone or ampicillin-sulbactam until clinically improved → oral step-down. Culture and sensitivity guide therapy. |
| Nursing Action | IV access for hospitalized patients. IV antibiotics as ordered. Antipyretics. Adequate hydration. Blood cultures if systemically ill. Monitor for progression to sepsis. Pain management for flank pain. |
| NCLEX Pearl | CVA tenderness + fever + chills + flank pain = pyelonephritis (upper UTI). WBC casts confirm renal parenchymal involvement. Treat more aggressively than cystitis (longer course, IV if severe). |
Catheter-Associated UTI (CAUTI)
UTI in a patient with an indwelling urinary catheter present for > 2 days at time of infection (or removed within 48h); most common healthcare-associated infection (HAI)
| Symptoms | Often minimal or absent (asymptomatic bacteriuria common — does NOT require treatment unless symptomatic or specific population). When symptomatic: fever, new onset or worsening delirium, catheter discomfort, flank pain, costovertebral angle tenderness, hypotension, rigors. |
| Common organisms | Polymicrobial; E. coli, Enterococcus, Pseudomonas, Candida, Klebsiella — more resistant patterns than community-acquired UTI |
| Urinalysis | Catheterized sample may show WBCs and bacteria even without true infection (biofilm colonization) — culture must correlate with clinical symptoms |
| Treatment overview | Remove catheter if possible (most important intervention). Culture-guided antibiotics for symptomatic CAUTI. Do NOT treat asymptomatic bacteriuria in most patients. |
| Nursing Action | CAUTI Prevention Bundle: (1) Insert only if clearly indicated, (2) Maintain closed sterile drainage system, (3) Keep bag below bladder level, (4) Empty bag every 8h or when 2/3 full — do NOT let bag touch floor, (5) Daily assessment of catheter necessity — remove ASAP, (6) Hand hygiene before/after any catheter manipulation, (7) Secure catheter to thigh to prevent traction. |
| NCLEX Pearl | Most important CAUTI prevention = remove catheter ASAP. Asymptomatic bacteriuria in catheterized patients generally NOT treated (except pregnant women, pre-urologic procedures). Keep bag below bladder level always. |
Urosepsis — Recognition
Urosepsis = UTI that has progressed to systemic infection (bacteremia and sepsis). Requires immediate intervention.
Sepsis 3 Criteria: Suspected infection + acute organ dysfunction (SOFA score ≥ 2). Septic shock: sepsis + MAP < 65 + vasopressor requirement + lactate > 2 mmol/L despite adequate fluids.
| Sign / Finding | Clinical Significance |
|---|---|
| Initial UTI symptoms | Dysuria, frequency, urgency → typically present before systemic deterioration |
| Temperature | Fever > 38°C (100.4°F) or < 36°C (hypothermia in septic shock) — hypothermia is an ominous sign |
| Heart rate | Tachycardia > 90 bpm (systemic inflammatory response) |
| Respiratory rate | Tachypnea > 20 breaths/min (compensating for metabolic acidosis) |
| Blood pressure | Initially maintained; MAP < 65 mmHg = septic shock (vasopressors required) |
| Altered mental status | Confusion, agitation, or obtundation — especially notable in elderly who may NOT have fever |
| Elevated lactate | Lactate > 2 mmol/L = tissue hypoperfusion; > 4 mmol/L = septic shock regardless of BP |
| Rigors/chills | Bacteremia — bacteria in bloodstream causing febrile rigors |
| Hypotension not responding to fluids | Septic shock — requires vasopressors (norepinephrine first-line) |
Urosepsis 1-Hour Bundle (SEP-1):
- Obtain blood cultures × 2 (before antibiotics if possible without delaying antibiotics)
- Administer broad-spectrum IV antibiotics within 1 hour
- Measure lactate (repeat if initial > 2 mmol/L)
- If MAP < 65 or lactate > 4: administer 30 mL/kg crystalloid bolus
- Apply vasopressors (norepinephrine) if MAP < 65 despite fluid resuscitation
Urine Specimen Collection
| Clean-catch midstream | Cleanse urethral meatus with antiseptic wipe (front to back in women). Begin urination, allow first few mL to drain, then collect midstream sample in sterile container. Reduces contamination with skin flora. |
| Catheterized sample | Preferred for indwelling catheter patients — obtain from designated sampling port using aseptic technique. Do NOT collect from drainage bag (bacterial overgrowth). |
| Timing | First morning void preferred (most concentrated, highest bacterial colony count if infected). Collect BEFORE antibiotics when possible. |
| Processing | Process immediately or refrigerate within 2h. Urine at room temperature allows bacterial overgrowth → false positive culture results. |
NCLEX Pearls
Dysuria + frequency + urgency + no fever = cystitis (lower UTI). Add CVA tenderness + fever + chills = pyelonephritis.
WBC casts = upper urinary tract (renal parenchymal) involvement — distinguishes pyelonephritis from cystitis.
Culture before antibiotics — get the specimen FIRST, then administer the antibiotic (do not delay antibiotics waiting for results, but draw culture first).
UTI in pregnancy: ALWAYS treat — even asymptomatic bacteriuria. Risk of pyelonephritis and preterm labor.
Most important CAUTI prevention = remove the catheter ASAP. Daily necessity assessment is required.
Asymptomatic bacteriuria in catheterized patients generally NOT treated (avoid antibiotic overuse/resistance). Exception: pregnant women, pre-urologic procedures.
Men: all UTIs are considered complicated (prostatitis must be considered; longer treatment course required).
Nitrofurantoin NOT for pyelonephritis (does not achieve adequate tissue levels) and contraindicated with eGFR < 30.
Related Resources
Standards & sources
Fact-checked Jun 21, 2026This page is written to align with KDIGO Clinical Practice Guidelines · National Kidney Foundation (NKF). It is an educational summary, not a citation of any single document — always verify specific doses, values, and protocols against current guidelines and your facility policy. How we source content →